Does celecoxib with sodium valproate have an augmentation effect on acute mania in bipolar disorder? A double-blind controlled clinical trial in Iran

Farhad Faridhosseini, Ali Talaei, Najmeh Shahini, Zanireh Salimi, Mahboubeh Eslamzadeh, Samira Ahrari, Meysam Pourgholami, Majid Khadem-Rezaiyan

Open source

DOI
10.1097/yic.0000000000000454
Published
2023-04-12
Container
International Clinical Psychopharmacology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/yic.0000000000000454,
  title = {Does celecoxib with sodium valproate have an augmentation effect on acute mania in bipolar disorder? A double-blind controlled clinical trial in Iran},
  author = {Farhad Faridhosseini and Ali Talaei and Najmeh Shahini and Zanireh Salimi and Mahboubeh Eslamzadeh and Samira Ahrari and Meysam Pourgholami and Majid Khadem-Rezaiyan},
  year = {2023},
  journal = {International Clinical Psychopharmacology},
  doi = {10.1097/yic.0000000000000454},
  url = {https://doi.org/10.1097/yic.0000000000000454}
}

RIS

TY  - JOUR
TI  - Does celecoxib with sodium valproate have an augmentation effect on acute mania in bipolar disorder? A double-blind controlled clinical trial in Iran
AU  - Farhad Faridhosseini
AU  - Ali Talaei
AU  - Najmeh Shahini
AU  - Zanireh Salimi
AU  - Mahboubeh Eslamzadeh
AU  - Samira Ahrari
AU  - Meysam Pourgholami
AU  - Majid Khadem-Rezaiyan
PY  - 2023
JO  - International Clinical Psychopharmacology
DO  - 10.1097/yic.0000000000000454
UR  - https://doi.org/10.1097/yic.0000000000000454
ER  - 

APA

Faridhosseini, F., Talaei, A., Shahini, N., Salimi, Z., Eslamzadeh, M., Ahrari, S., Pourgholami, M., & Khadem-Rezaiyan, M. (2023). Does celecoxib with sodium valproate have an augmentation effect on acute mania in bipolar disorder? A double-blind controlled clinical trial in Iran. International Clinical Psychopharmacology. https://doi.org/10.1097/yic.0000000000000454

Source records